Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy caused the patient's hair to have alternating thick and thin segments.

Hodgkin's lymphoma can show up as hair loss.

Two cycles of ABVD chemotherapy followed by 20 Gy radiotherapy is the new standard for early-stage Hodgkin lymphoma due to lower toxicity and similar effectiveness.

Chemotherapy successfully treated both Hodgkin's disease and skin lesions.

Alopecia areata can be an early sign of Hodgkin’s lymphoma and may improve with lymphoma treatment.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Chemotherapy can cause hair changes similar to alopecia areata, which might lead to misdiagnosis.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

About 22% of cancer patients had skin-related side effects from chemotherapy, but these were usually not severe enough to halt treatment.

Prevent persistent hair loss after chemotherapy with scalp cooling and early minoxidil use.

Some common medications can harm male fertility, but many effects can be reversed.

Medical treatments like chemotherapy and radiotherapy can harm sperm production, so freezing sperm before treatment is important for men who want children later.

Scalp cooling therapy is costly and often not covered by insurance, limiting access for low-income patients.

Cryotherapy helps reduce chemotherapy side effects but needs more research for best use.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Some medications and supplements can affect male fertility, with some improving and others harming sperm quality.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

MVP treatment is effective and safe for recurrent breast cancer.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

The treatment is safe and shows promise for metastatic breast cancer.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

Imuvert can prevent some chemotherapy-induced hair loss.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Vinblastine and its metabolites may cause nausea and hair loss by binding to specific receptors and could lead to better chemotherapy drugs with fewer side effects.

Bevacizumab may worsen hypothyroidism, so thyroid function should be monitored during treatment.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.